AMED - AMEDISYS INC

QQQ $ 447.95 $ -10.91 (-2.37 %)

DIA $ 397.31 $ -6.10 (-1.51 %)

SPY $ 532.92 $ -10.11 (-1.86 %)

TLT $ 98.17 $ 2.97 (3.12 %)

GLD $ 225.36 $ -0.43 (-0.19 %)

Previous Close

$ 98.07

Open

Bid

$ 98.06 x 200

Ask

$ 98.12 x 200

Day's Range

-- - --

52 Week Range

$ 89.55 - $ 98.95

Volume

352,075

Average Volume

Market Cap

3.24B

Beta (5Y Monthly)

$ 0.59

PE Ratio (TTM)

$ 35.23

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-25-2024	06-30-2024	10-Q
2	04-25-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	10-25-2023	09-30-2023	10-Q
5	07-27-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-16-2023	12-31-2022	10-K
8	10-27-2022	09-30-2022	10-Q
9	07-28-2022	06-30-2022	10-Q
10	04-28-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	04-29-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	10-29-2020	09-30-2020	10-Q
17	07-29-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	02-19-2020	12-31-2019	10-K
20	10-30-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-01-2019	03-31-2019	10-Q
23	02-28-2019	12-31-2018	10-K
24	10-30-2018	09-30-2018	10-Q
25	08-01-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	02-28-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	07-27-2017	06-30-2017	10-Q
30	05-03-2017	03-31-2017	10-Q
31	03-01-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-03-2016	06-30-2016	10-Q
34	05-04-2016	03-31-2016	10-Q
35	03-10-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	07-29-2015	06-30-2015	10-Q
38	04-29-2015	03-31-2015	10-Q
39	03-04-2015	12-31-2014	10-K
40	10-29-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Deutsche Bank Downgrades Amedisys to Hold,...
07/31/2024 11:48:30

Deutsche Bank analyst Justin Bowers downgrades Amedisys (NASDAQ:AMED) from Buy to Hold and maintains the price target from $...

Cantor Fitzgerald Reiterates Neutral on Am...
07/25/2024 13:52:56

Cantor Fitzgerald analyst Sarah James reiterates Amedisys (NASDAQ:AMED) with a Neutral and maintains $101 price target.

Amedisys Q2 EPS $1.32 Beats $1.18 Estimate...
07/24/2024 20:57:09

Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.18 by 11....

William Blair Downgrades Amedisys to Marke...
07/01/2024 12:38:39

William Blair analyst Matt Larew downgrades Amedisys (NASDAQ:AMED) from Outperform to Market Perform.

Cantor Fitzgerald Reiterates Neutral on Am...
04/25/2024 14:17:34

Cantor Fitzgerald analyst Sarah James reiterates Amedisys (NASDAQ:AMED) with a Neutral and maintains $101 price target.

Amedisys Q1 2024 Adj EPS $1.03 Beats $1.02...
04/24/2024 20:47:39

Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $1.02 by 0.9...

Raymond James Maintains Market Perform on ...
03/26/2024 17:21:43

Raymond James analyst John Ransom maintains Amedisys (NASDAQ:AMED) from Market Perform to Market Perform.

RBC Capital Maintains Outperform on Amedis...
03/25/2024 12:06:36

RBC Capital analyst Ben Hendrix maintains Amedisys (NASDAQ:AMED) with a Outperform and raises the price target from $97 to $...

Amedisys Q4 2023 Adj EPS $0.940 Misses $1....
03/05/2024 21:19:11

Amedisys (NASDAQ:AMED) reported quarterly earnings of $0.940 per share which missed the analyst consensus estimate of $1.030 by...

Amedisys Q4 2023 Adj EPS $0.94 Misses $1.0...
02/21/2024 22:09:50

Amedisys (NASDAQ:AMED) reported quarterly earnings of $0.94 per share which missed the analyst consensus estimate of $1.03 by 8...

Amedisys Offers Molecular Testing For Rapi...
02/08/2024 12:35:13

Amedisys, Inc. (NASDAQ:AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering adva...

Amedisys Q3 Adj. EPS $0.98 Misses $1.08 Es...
10/24/2023 20:44:39

Amedisys (NASDAQ:AMED) reported quarterly earnings of $0.98 per share which missed the analyst consensus estimate of $1.08 by 9...

Cantor Fitzgerald Maintains Neutral Rating...
09/14/2023 17:00:18

Cantor Fitzgerald Maintains Neutral on Ame...
09/14/2023 13:11:31

Cantor Fitzgerald analyst Sarah James maintains Amedisys (NASDAQ:AMED) with a Neutral and raises the price target from $100 ...

TD Cowen Maintains Market Perform on Amedi...
07/31/2023 19:43:15

TD Cowen analyst Gary Taylor maintains Amedisys (NASDAQ:AMED) with a Market Perform and raises the price target from $84 to ...

What 11 Analyst Ratings Have To Say About ...
07/27/2023 14:00:20

Credit Suisse Reiterates Neutral on Amedis...
07/27/2023 12:46:57

Credit Suisse analyst Jonathan Yong reiterates Amedisys (NASDAQ:AMED) with a Neutral and maintains $101 price target.

Amedisys Q2 Adj EPS $1.37 Beats $1.09 Esti...
07/26/2023 20:36:34

Amedisys (NASDAQ:AMED) reported quarterly adj earnings of $1.37 per share which beat the analyst consensus estimate of $1.09 by...

Benzinga's Top Ratings Upgrades, Downgrade...
07/06/2023 15:02:19

Meta Platforms To Rally Around 14%? Here A...
07/06/2023 12:43:35

Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi S...

CLASS ACTION DEADLINES - JOIN NOW!

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

AMEDAMEDISYS INC

Nasdaq amedisys.com

$ 98.07 $ -0.01 (-0.01 %)

Friday, 02-Aug-2024 15:59:57 EDT